On the Cusp: New Approaches for Multiple Myeloma

Program Goals

MM Novel Therapies

ELOQUENT-2 Phase 3 Trial Design

ELOQUENT-2 Efficacy and Safety Data

Elotuzumab +/- Vd Phase 2 Trial Design

Elotuzumab +/- Vd Phase 2 Trial Efficacy and Safety Data

MMY2002 SIRIUS Daratumumab Phase 2 Trial

ENDEAVOR Phase 3 Trial Design

ENDEAVOR Efficacy and Safety Data

CHAMPION-1 Once-Weekly Carfilzomib Phase 1/2 Trial

PANORAMA 1 Design, Efficacy, and Safety Data

PANORAMA 1 Subgroup Analysis

Panobinostat Other Combinations in RRMM

New Approaches for MM Summary

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)